Abiopharma

New Form SCHEDULE 13G/A - Helix Acquisition Corp. III <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003424 <b>Size:</b> 15 KB

New Form SCHEDULE 13G/A - Contineum Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003422 <b>Size:</b> 15 KB

New Form SCHEDULE 13G - Cyclerion Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003423 <b>Size:</b> 14 KB

New Form SCHEDULE 13G/A - Korro Bio, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003427 <b>Size:</b> 15 KB

New Form SCHEDULE 13G/A - CRESCENT BIOPHARMA, INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003420 <b>Size:</b> 15 KB

New Form SCHEDULE 13G - Cellectar Biosciences, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003421 <b>Size:</b> 15 KB

New Form EFFECT - Stereotaxis, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002656 <b>Size:</b> 1 KB

New Form EFFECT - Stereotaxis, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002657 <b>Size:</b> 1 KB

New Form EFFECT - Enlivex Ltd. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002658 <b>Size:</b> 2 KB

New Form EFFECT - SHOULDER INNOVATIONS, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002659 <b>Size:</b> 1 KB

New Form SCHEDULE 13G/A - Camp4 Therapeutics Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003419 <b>Size:</b> 15 KB

General Announcement: Changes to the Composition of the Board of Directors

Change - Announcement of Cessation: Resignation of Executive Director

6K-Kenon’s Subsidiary OPC Energy Ltd. Announces Offering of Series E Bondsto be listed on TASE

Notice of initial substantial holder